Table 1. Description of the participants and the success of the study.
Patient | Age (years) | Sex | Diagnosis | Clinical question, target pressure | Overall success |
---|---|---|---|---|---|
#1 | 38 | Male | Tricuspid atresia after modified Fontan-operation, RA-RVOT homograft | RVP | Yes |
#2 | 28 | Male | CoA, arterial hypertension | Pressure CoA | Yes |
#3 | 14 | Male | valvular AS and AR, Ross procedure, allograft, allograft stenosis | Pressure gradient RVOT | Yes |
#4 | 18 | Male | Pulmonary atresia, ASD II, BTA, AP-Shunt, PCPC, TCPC (extracardiac conduit), severe AR | Pressure gradient TCPC | Yes |
#5 | 55 | Female | Chronic pulmonary embolism, PAPVR upper left PV | Pressure RA | Yes |
#6 | 36 | Male | TOF, residual VSD, Shelhigh, Shelhigh stenosis, VSD | RVP, pressure gradient RVOT | Yes |
#7 | 55 | Male | Outlet VSD, PAPVR/ASD II, atrial fibrillation, arterial hypertension | RVP, pressure PA | Yes |
#8 | 19 | Male | PS, ASD II, valvuloplasty, transannular patch repair, ASD closure, severe PR and RV dilation | RVP | Yes |
#9 | 28 | Female | Situs inversus, azygos continuation, PAPVR, PAH | Pressure PA | No (complex morphology, PAH) |
#10 | 45 | Male | Ebstein's anomaly, TVR (bio), re-TVR (bio), VSD-closure, paroxysmal atrial fibrillation, RBBB; TV (mean 7 mmHg), residual VSD; TVR (interventional repair with Sapien valve) | Pressure RA and RVP | Yes |
#11 | 78 | Female | TOF; late VSD-closure, RV-PA-Conduit (bioprothesis), coronary artery disease, CABG, atrial fibrillation, RV-PA Stenosis | RVP, pressure PA | No (high degree IVC stenosis) |
#12 | 49 | Female | Aortic valve disease with AS and AR, Ross procedure; now slight obstruction of the RVOT and regurgitation (3rd degree, RV enlargement) | RVP | Yes |
#13 | 28 | Male | Severe valvular PS | RVP | Yes |
#14 | 39 | Male | Pulmonary atresia with VSD, PDA, Waterston-anastomosis, Rastelli operation; now: moderate allograft-stenosis and -regurgitation, severe AR, LV severely enlarged, LVEF (40%), ectasia of the aortic bulb and AoA | RVP | Yes |
#15 | 26 | Female | DORV (Taussig-Bing), TGA, CoA, PAB, Dilatation of re-CoA. Kawashima operation, VSD-closure, ventricular tachycardia, now: re-CoA | Pressure CoA | Yes |
#16 | 28 | Female | TAC, RPA- and LPA- stenosis; allograft, Infective endocarditis, allograft replacement, angioplasty of RPA and LPA, RPA- and LPA-stent; Now: intima proliferation in the stent | RVP | Yes |
#17 | 24 | Male | AS; Ross-Procedure, now: enlarged RV, severe PR | RVP | Yes |
#18 | 25 | Female | Ebstein’s anomaly, severe TR | Pressure RA | Yes |
#19 | 79 | Female | PDA, CoA | Pressure CoA | Yes |
#20 | 20 | Female | Ebstein's anomaly, Cone procedure, Now: Stenosis of “Cone valve” | Pressure gradient RV/RA |
Yes |
#21 | 46 | Female | ASD II | Pressure RA and RVP | Yes |
#22 | 17 | Male | DILV, PAB, pulmonary hypertension | Pressure RA and RVP | Yes |
#23 | 33 | Female | Tricuspid atresia, Fontan-operation, conversion to TCPC (extracardiac conduit) | Pressure gradient TCPC | Yes |
#24 | 25 | Female | VSD | Pressure RA and RVP | Yes |
#25 | 63 | Male | Ebstein’s anomaly, TR, PFO, arterial hypertension | Pressure RA and RVP | Yes |
AoA, ascending aorta; AP, aorto-pulmonary; AR, aortic regurgitation; AS, aortic stenosis; ASD, atrial septal defect; BTA, Blalock-Taussig anastomosis; CABG, coronary arterial by-pass graft; CoA, coarctation of the aorta; DILV, double inlet left ventricle; LPA, left pulmonary artery; PA, pulmonary artery; PAB, pulmonary artery banding; PAH, pulmonary arterial hypertension; PAPVR, partial anomalous pulmonary venous return; PCPC, partial cavo-pulmonary connection; PFO, persistent foramen ovale; PR, pulmonary regurgitation; PS, pulmonary stenosis; RA, right atrium; RPA, right pulmonary artery; RV, right ventricle; RVOT, right ventricular outflow tract; RVP, pressure right ventricle; TAC, truncus arteriosus communis; TCPC, total cavo-pulmonary connection; TGA, transposition of the great arteries; TOF, tetralogy of Fallot; TR, tricuspid regurgitation; TVR, tricuspid valve replacement; VSD, ventricular septal defect.